As cardiovascular disease is characterized by reduced nitric oxide bioavailability, our aim was to determine the impact of this change on the mechanism underlying vascular tone of pressurized arteries in vitro and in vivo.
Introduction
Vasoconstriction in response to increased intraluminal pressure and sympathetic nerve activation is initiated by depolarization of vascular smooth muscle cells and calcium entry through voltage-dependent calcium channels. 1 -4 Of the 10 molecular subtypes, the L-type channels are known to supply the calcium necessary for persistent vascular tone in both cerebral and systemic circulations 5, 6 and enhanced activity of L-type channels is linked to hypertension and cerebrovascular disease. 7 However, the T-type channels, Ca v 3.1 and Ca v 3.2, have recently been shown to be expressed in the renal, mesenteric, cerebral, skeletal muscle, and subcutaneous circulations and pharmacological studies have suggested that they contribute in combination with L-type channels to vascular tone of small arteries and arterioles. 8 -16 Endothelial dysfunction, a hallmark of hypertension and cardiovascular disease, is characterized by reduced nitric oxide bioavailability and increased oxidative stress, the latter resulting from up-regulated activity of a family of enzyme complexes called NADPH oxidases. 17, 18 Indeed, oxidative stress is generally considered to be responsible for the reduction in nitric oxide bioavailability, due to superoxide scavenging of nitric oxide as well as uncoupling of endothelial nitric oxide synthase, following reduction in its co-factor tetrahydrobiopterin. In wire myograph-mounted segments of middle cerebral arteries, acute inhibition of nitric oxide synthesis with N G -nitro-L-arginine methyl ester (L-NAME), has been shown to elicit vasoconstriction which was partially blocked by T-type channel antagonists; 21 however, the relevance of these data to the control of cerebrovascular tone under pressurized conditions, or to the control of peripheral vascular tone under physiological or pathophysiological conditions is unknown.
Our aim was three-fold: first, to determine the effect of acute inhibition of nitric oxide on the contribution of L-and T-type channels to vascular tone of pressurized cerebral arteries in vitro and systemic arterioles in vivo; secondly, to use Ca v 3.1 and Ca v 3.2 knockout mice to attribute effects of pharmacological blockade to molecular T-type channel subtypes, and thirdly, to investigate the effects of chronic nitric oxide inhibition, as occurs during cardiovascular disease, through the use of the L-NAME-treated animal model of hypertension.
Methods
Experiments were performed on Wistar rats (6 -8 In some experiments, C57BL/6 wild-type mice were treated for 14 -18 days with L-NAME (0.5 mg/mL, equivalent to 40 mg/kg/day for a 25 g mouse drinking 2 mL/day; Sigma-Aldrich, St Louis, MO, USA) in the drinking water. Blood pressure and heart rate were measured using tail cuff plethysmography on days 6, 8, and 9 of L-NAME treatment.
Cremaster muscle arteriolar preparation
Mice were anaesthetized intraperitoneally (1 mg/kg medetomidine, 10 mg/ kg midazolam; Pfizer Australia Pty Ltd, NSW Australia, 0.1 mg/kg fentanyl; Mayne Pharma Limited, Victoria, Australia) and continuously infused via a jugular vein catheter (medetomidine 0.02 mg/h; midazolam 0.2 mg/h; fentanyl 0.002 mg/h). Adequacy of anaesthesia was monitored by pedal response, according to animal Ethics Guidelines. Body temperature was maintained at 378C by a heating pad and mice were intubated with a polyethylene cannula to facilitate breathing. The right cremaster muscle was carefully dissected and spread over a coverslip to enable visualization of arterioles 23 L-NAME (10 mmol/L in the superfusate for 30 min) was used to acutely inhibit physiologically active nitric oxide, as preliminary data showed that subsequent addition of the nitric oxide scavenger, hydroxocobalamin (100 mmol/L), had no further effect on vascular tone (Total tone: L-NAME: 60 + 6.6 100-%D/D max ; L-NAME + hydroxocobalamin: 60 + 6.5 100-%D/D max ; n ¼ 31 arterioles/three mice). Our previous studies have shown that L-NAME treatment has no effect on resting membrane potential of either smooth muscle or endothelial cells of cremaster arterioles. 24 The contribution of L-and T-type channels to vascular tone was determined in the absence and the presence of L-NAME using nifedipine (1 mmol/L, 14 Sigma-Aldrich, St Louis, MO, USA) and the selective T-type channel antagonist NNC 55 -0396 25 -28 (3 mmol/L, 14 Tocris Bioscience, Bristol, UK), respectively. NNC was always added after nifedipine to prevent any non-specific action on L-type channels. Reversal of L-NAME action was tested with the nitric oxide donor, sodium nitroprusside (SNP, 100 nmol/L; Univar, Ingleburn, NSW, Australia). The concentration of SNP was chosen on the basis of our previous studies (pEC 50 of 7 29 ). In the chronic L-NAME-treated mice, the contribution of L-and T-type channels to vascular tone was determined before and after acute inhibition (30 Louis, MO, USA). The role of exogenous ROS was tested with hypoxanthine (250 mmol/L) and xanthine oxidase (3 mU/mL). 33 Arteries were superfused with hypoxanthine, and then with hypoxanthine and xanthine oxidase together. 
Pressure myography
Primary side branches of the basilar artery were removed from rats anaesthetized with 4% isoflurane in oxygen and decapitated. Arterial segments were cannulated, pressurized, and equilibrated in L-NAME or the control inactive isomer, D-NAME (10 mmol/L). Pressure -response curves were determined from 10 to 120 mmHg and repeated in nifedipine (1 mmol/ L, 14 Sigma-Aldrich, St Louis, MO, USA), then nifedipine and mibefradil
(1 mmol/L 14,34 ). Mibefradil was always added after nifedipine to prevent effects of non-specific action on L-type channels. 14, 34 The role of L-and T-type channels was normalized to D max , which was determined in calcium-free solution containing EGTA (1 mmol/L). Second-order mesenteric arteries were dissected from mice killed by cervical dislocation. Arterial segments were cannulated and pressurized to 60 mmHg with PSS containing 1% bovine serum albumen. After equilibration for 30 min, vessels were superfused with L-NAME (10 mmol/L) for 1 h. Since these vessels did not exhibit spontaneous vascular tone, vessels were pre-constricted with phenylephrine (1 mmol/L) to simulate neurovascular tone, and then incubated cumulatively in nifedipine (1 mmol/L) and NNC 55 -0396 (3 mmol/L).
14 Vessel diameter was recorded in each drug solution, maximum diameter determined in calcium-free PSS, and the contribution of L-and T-type channels normalized to D max .
Immunohistochemistry
Basilar arteries were incubated in L-NAME (10 mmol/L) in PSS for 30 min at 378C and smooth muscle cells isolated, 14 fixed in 2% paraformaldehyde, and stained with antibodies against Ca v 3.1 (1 : 500; kindly provided by Dr L.L.Cribbs, Loyola University, Chicago, IL, USA). Staining was quantified in defined areas in the cytoplasm and near the membrane, using the thresholding function of ImageJ. Intact cremaster muscles were isolated from mice euthanized by cervical dislocation, pinned flat, fixed, stained with rabbit anti-Ca v 1.2
(1:300), anti-Ca v 3.1 (1:500), or anti-Ca v 3.2 (1:300, kindly provided by Dr L.L.Cribbs) and analysed with ImageJ.
Dihydroethidium staining
Control mice and mice chronically treated with L-NAME were anaesthetized with isoflurane, decapitated and cremaster arterioles and surrounding skeletal muscle, as well as mesenteric arteries removed. Cryostat sections were incubated with or without dihydroethidium (2 mmol/L, Sigma-Aldrich, St Louis, MO, USA) and nuclear staining intensity analysed with ImageJ. In order to determine whether superoxide was the main product involved in the fluorescent signal, additional sections were incubated in dihydroethidium, with or without polyethylene glycol-superoxide dismutase (PEG-SOD; 250 Units/mL).
Detailed Methods are provided in Supplementary material online.
Results

Acute inhibition of nitric oxide increases the contribution of T-type channels to tone of pressurized cerebral arteries in vitro
Acute treatment of pressurized basilar arterial branches (D max ¼ 189 + 6 mm, n ¼ 10) with L-NAME (10 mmol/L) produced a significant leftward shift in the pressure-response curve ( Figure 1A ) and significant increase in the contribution of T-type channels to vascular tone at all intraluminal pressures, compared with treatment with the inactive control, D-NAME ( Figure 1C ). This was accompanied by a significant decrease in the contribution of L-type channels from 40 to 120 mmHg ( Figure 1B ).
Acute inhibition of nitric oxide increases membrane expression of Ca v 3.1 in isolated cerebrovascular smooth muscle cells
Incubation of cerebral vessels in L-NAME at 378C led to a significant redistribution of Ca v 3.1 staining from the cytoplasm in the absence of L-NAME, to a region near the cell membrane ( Figure 2A and B). Incubation of vessels in L-NAME at room temperature failed to significantly alter distribution ( Figure 2A and B) suggesting an energy-dependent mechanism. No staining was seen without the primary antibody. Experiments were not conducted with antibodies against Ca v 3.2 due to a failure to produce significant staining of isolated smooth muscle cells. 14 
Acute inhibition of nitric oxide increases the contribution of T-type channels to tone of cremaster muscle arterioles in vivo
Cremaster arterioles were divided into four groups according to the degree of vascular tone ( Figure 3A-D Figure 3A-D) .
Acute superfusion with L-NAME (10 mmol/L) had no effect on tone of the two smallest arterial groups with the highest tone ( Figure 3A and B), but significantly increased tone in the two larger groups ( Figure 3C and D) . While the contribution of L-type channels was not affected by acute L-NAME treatment, the contribution of T-type channels was significantly increased in all but the smallest arteriolar group ( Figure 3B -D, cf. 3A) .
In order to combine data from all arterioles in spite of varying degrees of vascular tone, we normalized expression of L-and T-type channels in each arteriole to vascular tone. Combined data Figure 1 Contribution of T-type channels is increased by acute L-NAME treatment of pressurized rat cerebral arteries in vitro. (A) Myogenic tone increased with intraluminal pressure in arteries acutely treated with L-NAME treatment (10 mmol/L; n ¼ 6 arteries) or the control inactive isomer, D-NAME (10 mmol/L; n ¼ 4 arteries). (B) L-NAME treatment significantly decreased the contribution of L-type channels to myogenic tone from 40 to 120 mmHg. (C ) L-NAME also significantly increased the contribution of T-type channels to myogenic tone across the pressure range. Data represent means + SEM. *P , 0.05 from corresponding response in D-NAME.
showed that acute L-NAME treatment significantly increased mean vessel tone and the relative contribution of T-type channels, but reduced the contribution of L-type channels (P , 0.05; Figure 3E and F ).
The effect of acute L-NAME treatment on the contribution of L-type and T-type channels was reversed by superfusion with the nitric oxide donor, SNP (100 nmol/L; Supplementary material online, Figure S1 ).
Acute inhibition of nitric oxide increases expression of T-type channels in cremaster muscle arterioles
Immunohistochemical staining for Ca v 1.2, L-type channels was abundant in smooth muscle cells of cremaster arterioles, with no significant change following acute incubation with L-NAME (Figure 4A and B; Supplementary material online, Figure S2 ; P . 0.05). In contrast, Ca v 3.1 staining was weak in smooth muscle cells under control conditions, but significantly increased after incubation with L-NAME (Figure 4C and D; Supplementary material online, Figure S2 ; P , 0.05). Staining for Ca v 3.2 was frequently absent from smooth muscle cells of cremaster arterioles, but became apparent after L-NAME exposure (Figure 4E and F; Supplementary material online, Figure S2 ; P , 0.05). No staining was observed without the primary antibody.
3.5 Contribution of T-type channels to vascular tone is less in arteries from Ca v 3.2ko mice than in wild-type mice following acute L-NAME treatment L-and T-type channels contributed equally to phenylephrine (1 mmol/L)-induced vascular tone of second-order mesenteric Arterioles were divided into four groups according to myogenic tone (black bars). Acute L-NAME treatment significantly increased vascular tone for the two groups with the least endogenous tone (C and D). The contribution of L-type channels to vascular tone was not affected by L-NAME (white bars), while the T-type channel contribution was significantly increased by L-NAME for all but the most constricted arterioles (hatched bars; B-D, cf. A). (E and F ) When data from all arterioles were pooled (107 arterioles/9 mice), acute L-NAME treatment significantly increased vascular tone (E), and the relative contribution of T-type channels to tone (F ). Data represent means + SEM. *P , 0.05 significantly different from corresponding no treatment (NT) control.
arteries from wild-type mice under conditions of acute inhibition of nitric oxide ( Figure 5A ). In contrast, in arteries isolated from Ca v 3.1ko and Ca v 3.2ko mice, the contribution to tone of T-type channels was significantly smaller than that of L-type channels (P , 0.05; Figure 5B and C ) and for Ca v 3.2ko arteries, the contribution of T-type channels was significantly less than that in wild-type vessels (P , 0.05; Figure 5C , cf. 5A). Although there was a trend to an increase in the contribution of L-type channels to tone in arteries from both Ca v 3.1ko and Ca v 3.2ko mice, this was not statistically significant (P . 0.05).
Chronic inhibition of nitric oxide increases the contribution of T-type channels to tone of cremaster muscle arterioles in vivo
Chronic exposure of wild-type mice to L-NAME for 14-18 days caused a significant rise in blood pressure which was maximal by in arteries from Ca v 3.2ko than wild-type mice following acute L-NAME treatment. (A) L-and T-type channels contribute equally to phenylephrine-induced vascular tone of mesenteric arteries from wild-type mice. (B and C) In mesenteric arteries from Ca v 3.1ko and Ca v 3.2ko mice, the contribution of T-type channels was significantly less than that of L-type channels. T-type channel involvement in Ca v 3.2ko arteries was also significantly less than that in wild-type arteries. Data represent means + SEM for six arteries (wild-type), six arteries (Ca v 3.1ko), eight arteries (Ca v 3.2ko). *P , 0.05 significant difference between L-and T-type contributions. **P , 0.05 significantly different from corresponding wild-type value.
Day 6 of treatment (Day 6: L-NAME: 121 + 5 mmHg; Day 9: L-NAME: 121 + 3 mmHg, n ¼ 5 mice; P . 0.05; cf. no treatment: 107 + 5 mmHg; P , 0.05). Heart rate did not vary between L-NAME-treated and untreated mice (L-NAME: 603 + 30 bpm, n ¼ 5 mice; untreated: 670 + 30 bpm, n ¼ 5 mice; P . 0.05).
When data for all vessels were considered, the relative contribution of T-type channels to tone was significantly increased by chronic L-NAME treatment, compared with untreated mice, without significant change in either L-type channels or vascular tone (Chronic L-NAME: Figure 6A and B, cf. no treatment, NT: Figure 3E and F ) .
When cremaster arterioles were divided into four groups by vascular tone (Supplementary material online, Figure S3 : 70-100% tone, D max ¼ 30.0 + 3.4 mm, 15 arterioles/six mice; 50-69% tone, D max ¼ 42.9 + 4.9 mm, 28 arterioles/nine mice; 30-49% tone, D max ¼ 49.9 + 4.9 mm, 27 arterioles/eight mice; 1-29% tone, D max ¼ 79.4 + 7.0 mm, 34 arterioles/eight mice), the contribution of T-type channels was significantly increased in the three larger vessel groups (P , 0.05) but not in the smallest vessel group, compared with arterioles from untreated wild-type mice (Chronic L-NAME: Supplementary material online, Figure S3A -D, cf. NT: Figure 3A-D) . In contrast, the contribution of L-type channels to tone was unchanged in the three smaller vessel groups (P . 0.05) but significantly decreased in the largest vessel group (Chronic L-NAME: Supplementary material online, Figure S3A 
Oxidative stress is causal to the increased contribution of T-type channels following chronic inhibition of nitric oxide
Acute treatment with the superoxide dismutase mimetic, tempol (1 mmol/L), of cremaster arterioles of mice chronically treated with L-NAME, significantly reduced tone ( Figure 6A ) and reversed the increased contribution of T-type channels to vascular tone ( Figure 6B) . Analysis of vessel sub-groups showed that acute tempol treatment significantly reduced tone in all, but the largest vessel group with the least tone (Supplementary material online, Figure  S3A-D) . The contribution of T-type channels to tone was significantly reduced in all groups, while the contribution of L-type channels was significantly reduced in the smallest vessel group but not in the three other groups (Supplementary material online, Figure S3A-D) . Control experiments in cremaster arterioles of mice acutely superfused with tempol, but not subjected to chronic treatment with L-NAME, showed that both vascular tone and the contribution of L-or T-type channels were not significantly different from untreated mice (Vessel tone: 41.2 + 7.3 100-%D/D max ; L-type, 63.9 + 5.9% contribution to vessel tone; T-type, 23.7 + 3.4% contribution to vessel tone; 42 arterioles/four mice; P . 0.05 cf. NT; Figure 3E and F ).
In order to test a role for NADPH oxidases in the changes in calcium-channel subtypes initiated by chronic L-NAME treatment, we conducted further experiments using the NADPH oxidase inhibitor, apocynin, and the flavin inhibitor, DPI, acutely on cremaster arterioles. Consistent with the data obtained with tempol, both drugs caused a significant reduction in vascular tone and the relative contribution of T-type channels ( Figure 6C and D) .
When cremaster muscle arterioles were analysed according to the degree of vascular tone (Supplementary material online, Figure  S4A- Figure  S4A-D) .
The role of ROS in altering the contribution of T-type channels was confirmed by superfusion of untreated arterioles with the ROS generating system, hypoxanthine and xanthine oxidase. Exogenous application of hypoxanthine led to a decrease in vessel tone without change in the relative contribution of L-and T-type channels (Supplementary material online, Figure S5 ). Addition of xanthine oxidase to hypoxanthine did not affect vascular tone, but significantly reduced the contribution of L-type channels and significantly increased the contribution of T-type channels (Supplementary material online, Figure S5 ). Addition of hypoxanthine and xanthine oxidase, in the presence of L-NAME, did not significantly increase the T-type channel contribution to vascular tone, compared with that already elicited by elimination of nitric oxide (L-NAME: Vessel tone: 56.5 + 2.7 100-%D/D max ; L-type, 44.7 + 9.0% contribution to vessel tone; T-type, 34.9 + 3.0% contribution to vessel tone; L-NAME + Figure 6 Contribution of T-type channels to vascular tone of mouse cremaster arterioles in vivo is increased by chronic L-NAME treatment, but abolished by inhibition of ROS. (A and B) Acute treatment with the superoxide dismutase mimetic, tempol (1 mmol/L), produced a significant decrease in vascular tone (A), and abolished the contribution of T-type channels (B; L-NAME chronic, 104 arterioles/9 mice; +Tempol, 80 arterioles/7 mice). (C and D) Inhibition of NADPH oxidases with apocynin (Ap; 500 mmol/L) and DPI (5 mmol/ L) produced a significant decrease in vascular tone (C), and the relative contribution of T-type channels to vascular tone (D; L-NAME chronic, 155 arterioles/14 mice; apocynin, 78 arterioles/7 mice; DPI, 54 arterioles/5 mice). Data represent means + SEM. *P , 0.05 significantly different from corresponding chronic L-NAME value.
hypoxanthine + xanthine oxidase: Vessel tone: 43.0 + 2.7 100-%D/ D max ; L-type, 45.2 + 8.7% contribution to vessel tone; T-type, 50.3 + 9.0% contribution to vessel tone; 41 arterioles/four mice).
Chronic inhibition of nitric oxide increases superoxide in vascular smooth muscle cells
Chronic exposure to L-NAME significantly increased dihydroethidium staining of smooth muscle cell nuclei in both cremaster arterioles and mesenteric arteries, compared with those of untreated wild-type mice (Supplementary material online, Figure S6 ; cremaster arterioles: Chronic L-NAME: 60 + 4 pixel intensity, n ¼ 49 nuclei/five arteries; NT: 35 + 7 pixel intensity, n ¼ 43 nuclei/five arteries; P , 0.05; mesenteric arteries: Chronic L-NAME: 56 + 8 pixel intensity, n ¼ 84 nuclei/12 arteries; NT: 30 + 5 pixel intensity, n ¼ 72 nuclei/11 arteries; P , 0.05). Control sections incubated without dihydroethidium showed no nuclear labelling.
Incubation of arterial sections with dihydroethidium in the presence of PEG-SOD significantly reduced the staining intensity in both vessels, indicating that superoxide was the main fluorescent product (cremaster arterioles: Chronic L-NAME + PEG-SOD: 23 + 4 pixel intensity, n ¼ 25 nuclei/four arteries; chronic L-NAME -PEG-SOD: 64 + 12 pixel intensity, n ¼ 48 nuclei/five arteries; P , 0.05; mesenteric arteries: Chronic L-NAME + PEG-SOD: 37 + 3 pixel intensity, n ¼ 58 nuclei/six arteries; chronic L-NAME -PEG-SOD: 84 + 8 pixel intensity, n ¼ 49 nuclei/six arteries; P , 0.05).
Discussion
The present study provides a novel insight into how nitric oxide modulates peripheral vascular tone. The major findings are (i) that acute and chronic inhibition of nitric oxide produces a significant increase in T-type channel involvement in resistance vessels, (ii) that this change in electromechanical coupling results from increased bioavailability of superoxide produced from NADPH oxidase, and (iii) that the effects result from specific actions on the molecular T-channel subtypes, Ca v 3.1 and Ca v 3.2. Together these data provide the first evidence that nitric oxide plays an active role in limiting the bioavailability of ROS. Under pathophysiological conditions of reduced nitric oxide bioavailability, superoxide levels are increased and the T-type calciumchannel contribution to peripheral vascular tone is augmented, due to increased expression and/or redistribution of channels to the cell membrane.
Acute nitric oxide deficit increases vascular tone through recruitment of T-type channels
Our initial studies investigated the effects of acute inhibition of nitric oxide on the contribution of L-and T-type channels to vascular tone of pressurized vessels. We found that vascular tone was increased in cerebral arteries in vitro and in skeletal muscle arterioles in vivo, and that this resulted from a selective increase in the contribution of T-type channels, but not L-type channels (Figures 1 and 3) . The full reversal of this effect following superfusion with SNP (Supplementary material online, Figure S1 ) suggests a negative regulation of T-type channel function by nitric oxide. In the cerebral vessels, the increased involvement of T-type channels was accompanied by a significant decrease in the contribution of L-type channels at intraluminal pressures .40 mmHg. Our data obtained from cerebral myocytes showed that the rapidity of this change in electromechanical coupling could be explained by increased trafficking of T-type channels from the cytoplasm to the cell membrane (Figure 2) , while in skeletal muscle arterioles in situ, acute nitric oxide inhibition significantly increased protein expression of T-type channels in smooth muscle cells (Figure 4 ; Supplementary material online, Figure S2 ). The increased activity of Ca v 3.2 channels in nociceptive primary sensory neurones in a model of irritable bowel syndrome has also been attributed to rapid insertion of channels into the cell membrane. 35 In the cremaster muscle microcirculation in vivo, the change in electromechanical coupling following nitric oxide deficit was found in all except the smallest arterioles, where nitric oxide did not play any role in regulating vascular tone and T-channels contributed to vasoconstriction under physiological conditions ( Figure 3A) . Such a contribution of T-type channels to normal vascular tone has been found in small vessels of other vascular beds. 14, 16, 36 Coupled with a diminishing role for nitric oxide in endothelial vasodilation as vessel size decreases, 37, 38 these data support the proposal that nitric oxide negatively regulates T-type channel function.
Chronic nitric oxide deficit increases the contribution of T-type channels through increased oxidative stress
Chronic inhibition of nitric oxide with L-NAME has been widely used as an animal model of hypertension to probe the effect of nitric oxide deficit 39 and our data confirmed that this treatment led to a rapid and significant increase in blood pressure. Chronic L-NAME treatment also increased the contribution of T-type channels to vascular tone; again in all but the smallest arterioles (Supplementary material online, Figures S3 and S4) . The increased T-type component following chronic L-NAME treatment resulted from reduction in a small non-L-, non-T-type component of vascular tone, except in the largest arterioles, in which the L-type component was significantly reduced. As cardiovascular disease is characterized by increased ROS resulting from the activation of NADPH oxidases, 17 we tested the involvement of this pathway in the recruitment of T-type channels by chronic nitric oxide deficit. We found that superoxide was significantly increased in the arterial smooth muscle of mice after chronic L-NAME treatment (Supplementary material online, Figure S6) ; treatment with PEG-SOD significantly attenuating the fluorescent signal generated in the presence of dihydroethidium. Furthermore, the superoxide dismutase mimetic, tempol, and NADPH oxidase inhibitors, apocynin and DPI, completely reversed the T-type channel recruitment to vascular tone induced by nitric oxide deficit ( Figure 6 ). These data suggest that nitric oxide deficit increases the bioavailability of superoxide from the NADPH oxidase pathway and that this increases the T-type channel contribution to vascular tone. Such an indirect effect of nitric oxide is supported by the failure of nitric oxide donors to inhibit T-type currents in isolated vascular smooth muscle cells. 40 While activation of soluble guanylate cyclase is a prominent downstream action of nitric oxide, many of the cardioprotective effects of nitric oxide are independent of guanylate cyclase and instead due to modification of cell proteins by S-nitrosylation. 41 Interestingly, nitric oxide has been reported to suppress NADPH-oxidase-dependent superoxide production by S-nitrosylation of the cytosolic p47 phox subunit, 42 which is required for the activation of both Nox1 and Nox2 subunits. 17 Thus it is possible that deficiency in nitric oxide may release this suppression of NADPH-oxidase, thereby increasing superoxide synthesis. However, a comprehensive study of the role of potential downstream signalling molecules activated by nitric oxide and their effects on the regulation of bioactive ROS is needed to validate these predictions. The role of ROS in controlling T-type channel function was confirmed by the increased T-type channel contribution to vascular tone induced by exogenous ROS production from xanthine oxidase (Supplementary material online, Figure S5 ). The absence of a significant increase in the T-type channel contribution induced by exogenous ROS over those effects already induced by inhibition of nitric oxide with L-NAME, suggests that the effects of ROS in increasing T-channel involvement were already maximal. Recent studies in chromaffin cells, cardiomyocytes, and sensory neurones have provided evidence for redox regulation of both T-type channel mRNA expression and T-type channel activity. 43 -45 Although arterial L-type channel activity has also been reported to be up-regulated by ROS, 33 we did not find any such effects on L-type channels here. However, our data indicate that superoxide up-regulates T-type channel activity, in contrast to the hydrogen peroxide-mediated stimulation of arterial L-type channels. 46 The recent demonstration of hydrogen peroxide-mediated inhibition of T-type channel activity 47 suggests a complex regulation of calciumchannel activity by different ROS. While the effects described here are indicative of a role for NADPH oxidase activity, it should be noted that apocynin can have direct antioxidant actions 48 and DPI will inhibit the activity of other flavin containing enzymes. 17 Future studies in mice deficient in specific NADPH oxidase subtypes will therefore be necessary to delineate the involvement of these different isoforms in the increased superoxide production. Nevertheless, the present study has demonstrated nitric oxide deficit as a direct or indirect cause of increased oxidative stress; a feedback loop which could exacerbate tissue damage.
4.3 Ca v 3.1 and Ca v 3.2 are the molecular targets for T-type channel antagonism T-type channels have been attributed a role in vasoconstriction of small vessels in a number of vascular beds, 15 due to arterial expression of the molecular channel subtypes, Ca v 3.1 and Ca v 3.2, and reduction in vasomotor responses following application of T-type channel antagonists. 8 -14,16 However, many of the T-type pharmacological agents used previously have been reported to lack specificity and therefore a role for T-type channels in vascular tone remains controversial. 12, 15, 49 We reasoned that if the pharmacological antagonist, NNC 55 -0396, was selective for the molecular T-channel subtypes, then it should have a reduced effect on the residual vascular tone of arteries from Ca v 3.1ko, or Ca v 3.2ko mice, after blockade of L-type channels with nifedipine. Our data obtained in mesenteric arteries of Ca v 3.1ko or Ca v 3.2ko mice confirm these predictions, demonstrating for the first time the involvement of Ca v 3.2 channels, and to a lesser degree, Ca v 3.1 channels, in vascular tone during nitric oxide deficiency ( Figure 5 ).
Summary
We show that under normal physiological conditions in vivo, T-type channels contribute to vascular tone of the smallest arterioles, in which nitric oxide does not play a role in vasodilation. In contrast, in larger vessels, chronic inhibition of nitric oxide increases T-type channel contribution to peripheral vascular tone, due to augmentation of superoxide bioavailability through the NADPH oxidase pathway. We further show that the effects of the T-type channel antagonist, NNC 55-0396, are mediated by the Ca v 3.1 and Ca v 3.2 T-type molecular subtypes and that the increased contribution of these channels results from increased expression or redistribution of protein to the cell membrane. Interestingly, the central region of the I-II loop of both Ca v 3.1 and Ca v 3.2 has been identified as integral to the regulation of surface expression of these channels 10, 50 and may be the target for these effects. Importantly, we provide evidence for a novel causal link between nitric oxide deficit, increased oxidative stress, and T-type channel function. Future studies should be directed to identifying the NADPH oxidase subtypes involved in these effects and the mechanism/s by which superoxide augments T-type channel activity.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
